Labcorp Partners with Roche to Expand Digital Pathology and Advance AI Integration in Diagnostics
Labcorp Holdings Inc. has announced a collaboration with Roche to advance digital pathology capabilities across its diagnostics and biopharma laboratory services. Through this partnership, Labcorp will implement Roche's FDA-cleared VENTANA® DP 600 and DP 200 slide scanners, enabling pathologists to diagnose patients using digital images and supporting future integration of artificial intelligence. The initiative is designed to improve diagnostic accuracy, streamline operations, and facilitate efficient data sharing and centralized review, particularly in the face of a projected shortage of pathologists in the U.S. This collaboration builds on Labcorp's ongoing relationship with Roche and aims to enhance patient care through innovative technology solutions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Labcorp Holdings Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: DC86578) on September 30, 2025, and is solely responsible for the information contained therein.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。